Ironwood Pharmaceuticals IRWD Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's pre-tax income?
- Ironwood Pharmaceuticals (IRWD) reported pre-tax income of $65.17M in Q1 2026.
- How has Ironwood Pharmaceuticals's pre-tax income changed year-over-year?
- Ironwood Pharmaceuticals's pre-tax income increased by 279.7% year-over-year, from -$36.27M to $65.17M.
- What is the long-term trend for Ironwood Pharmaceuticals's pre-tax income?
- Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's pre-tax income has grown at a -23.1% compound annual growth rate (CAGR), from $200.66M to $70.03M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.